HRT: some unresolved clinical issues in breast cancer, endometrial cancer and premature ovarian insufficiency

Author： Davey Dennis A  

Publisher： Future Medicine

ISSN： 1745-5057

Source： Women's Health, Vol.9, Iss.1, 2013-01, pp. : 59-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ovarian stimulation: is there a long-term risk for ovarian, breast and endometrial cancer?

By Lerner-Geva L   Rabinovici J   Lunenfeld B  

Women's Health, Vol. 6, Iss. 6, 2010-11 ,pp. : 831-839

Future Medicine

Access to resources Recommend Favorite

Ovarian function suppression is beneficial in some premenopausal women with early breast cancer

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 66, Iss. 5, 2016-09 ,pp. : 355-356

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prophylactic Surgery to Reduce the Risk of Developing Breast Cancer:Issues and Clinical Implications

By  

Current Women's Health Reviews, Vol. 8, Iss. 1, 2012-02 ,pp. : 94-103

Bentham Science Publishers

Access to resources Recommend Favorite

HRT and breast cancer: recent findings in the context of the evidence to date

By Banks Emily   Canfell Karen   Reeves Gillian  

Women's Health, Vol. 4, Iss. 5, 2008-09 ,pp. : 427-431

Future Medicine

Access to resources Recommend Favorite

Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors

By  

CANCER, Vol. 121, Iss. 13, 2015-07 ,pp. : 2147-2155

John Wiley & Sons Inc

Access to resources Recommend Favorite